Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Data Source This retrospective cohort study utilized administrative claims data from IQVIA’s PharMetrics Plus database to identify pwT1D from April 1, 2016, through April 30, 2020. The overall study period was October 1, 2015, to April 30, 2022, to allow at least two years of follow-up.
Abstract Introduction Spasticity and cervical dystonia (CD) are movement disorders with considerable direct and indirect healthcare cost implications. Although several studies have discussed their clinical impact, few have calculated the economic burden of these disorders. This study aimed to understand treatment/injection patterns of botulinum toxins type A (BoNT-As) and the characteristics, healthcare resource utilization (HCRU), and costs among patients with spasticity or CD.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.